Annals of Clinical and Translational Neurology

Article	Citations
	105
Evaluating brain damage in multiple sclerosis with simultaneous multi‐angular‐relaxometry of tissue	101
Quantitative signal properties from standardized MRIs correlate with multiple sclerosis disability	71
Cerebral hypoperfusion reduces tau accumulation	64
Skull defect – Frontotemporal dementia sagging brain syndrome	62
Cognitive impairment in pulmonary arterial hypertension	60
Assessment of burden and segregation profiles of CNVs in patients with epilepsy	60
Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes	55
Phosphorylated alpha‐synuclein in Iba1‐positive macrophages in the skin of patients with Parkinson's disease	52
Brain imaging signatures in amyotrophic lateral sclerosis: Correlation with peripheral motor degeneration	49
Objective sleep was longitudinally associated with brain amyloid burden in mild cognitive impairment	47
High‐dose IgG suppresses local inflammation and facilitates functional recovery after olfactory system injury	47
Issue Information	46
Epitope Mapping of Anti‐Neurofascin 155 Antibody in a Large Cohort of Autoimmune Nodopathy Patients	45
Impaired gating of γ‐ and ε‐AChR respectively causes Escobar syndrome and fast‐channel myasthenia	43
Cortical lesions impact cognitive decline in multiple sclerosis via volume loss of nonlesional cortex	41
Refractory myasthenia gravis treated with autologous hematopoietic stem cell transplantation	41
ALS plasma biomarkers reveal neurofilament and pTau correlate with disease onset and progression	39
Issue Information	39
Neurological diagnoses in hospitalized COVID‐19 patients during the B.1.1.529 surge	36
Optimized microburst VNS elicits fMRI responses beyond thalamic‐specific response from standard VNS	35
Infarct‐related structural disconnection and delirium in surgical aortic valve replacement patients	35
Hypertension management in elderly with severe intracerebral hemorrhage	35
Subcutaneous batoclimab in generalized myasthenia gravis: Results from a Phase 2a trial with an open‐label extension	35
Amyloid‐dependent and amyloid‐independent effects of Tau in individuals without dementia	33

Issue Information	31
Discrepant expressive language lateralization in children and adolescents with epilepsy	31
Diagnostic capabilities of nanopore long‐read sequencing in muscular dystrophy	30
Reduced Bergmann glial process terminations and lateral appendages in essential tremor	30
Auditory neuropathy in mice and humans with Friedreich ataxia	30
Muscle magnetic resonance imaging involvement patterns in nemaline myopathies	30
Issue Information	30
Hypotonia–cystinuria 2p21 deletion syndrome: Intrafamilial variability of clinical expression	30
Linking autism spectrum disorders and parkinsonism: clinical and genetic association	29
The anterior nucleus of the thalamus plays a role in the epileptic network	29
HLA in isolated REM sleep behavior disorder and Lewy body dementia	29
Longitudinal evaluation of neurologic‐post acute sequelae SARS‐CoV‐2 infection symptoms	29
CYLD variants identified in Alzheimer's disease and frontotemporal dementia patients	29
SCAR32: Functional characterization and expansion of the clinical‐genetic spectrum	28
Serum neurofilament light chain and cognition decline in US elderly: A cross‐sectional study	28
Issue Information	28
Baseline systolic blood pressure, hypertension history, and efficacy of remote ischemic conditioning	28
Glycated hemoglobin A1c, cerebral small vessel disease burden, and disease severity in Parkinson's disease	27
The safety and efficacy of intravenous immunoglobulin in autoimmune encephalitis	27
Anakinra treatment for refractory cerebral autoinflammatory responses	27
A multi‐omics study to monitor senescence‐associated secretory phenotypes of Alzheimer's disease	26
WiTNNess: An international natural history study of infantile‐onset TNNT1 myopathy	26
PRNP expression predicts imaging findings in sporadic Creutzfeldt‐Jakob disease	26
Autophagy‐related 5 in acute ischemic stroke: Variation and linkage with neurofunction, and survival	26
Cobb syndrome effectively treated with trametinib	25
T1−/T2‐weighted ratio reveals no alterations to gray matter myelination in temporal lobe epilepsy	25
Impact of cerebral collateral flow on stroke outcomes after carotid stenting	25
B cell and aquaporin‐4 antibody relationships with neuromyelitis optica spectrum disorder activity	24
Issue Information	23
Increased systemic HSP70B levels in spinal muscular atrophy infants	23
Postoperative changes in cognition and cerebrospinal fluid neurodegenerative disease biomarkers	23
Sensitivity and specificity of the Salzburg EEG criteria for nonconvulsive status epilepticus	23
Juvenile‐onset Huntington's disease – Spectrum and evolution of presenting movement disorders	23
Order from chaos: Using CSF proteomics to predict ALS progression	23
Early‐onset leukoencephalomyelopathy due to a biallelic NDUFV1 variant in a mid‐forties patient	23
Characterizing mortality in patients with AQP4‐Ab+ neuromyelitis optica spectrum disorder	23
Micro‐diffusely abnormal white matter: An early multiple sclerosis lesion phase with intensified myelin blistering	22
Immune responses to SARS‐CoV‐2 vaccination in multiple sclerosis: a systematic review/meta‐analysis	22
Repeated iv anti‐CD20 treatment in multiple sclerosis: Long‐term effects on peripheral immune cell subsets	22
Lactate dehydrogenase predicting mortality in patients with aneurysmal subarachnoid hemorrhage	22
Consistency of electrical source imaging in presurgical evaluation of epilepsy across different vigilance states	22
COVID‐19 clinical outcomes and DMT of MS patients and population‐based controls	22
Novel pathogenic mtDNA variants in Chinese children with neurological mitochondrial disorders	22
Reliability and validity of digital health metrics for assessing arm and hand impairments in an ataxic disorder	21
In vivo detection of poststroke cerebral cell proliferation in rodents and humans	21
Associations of Cerebrospinal Fluid Orexin‐A, Alzheimer Disease Biomarkers, and Cognitive Performance	20
Incremental clinical value of intraplaque neovascularization in predicting recurrent ischemic stroke	20
Neuromuscular transmission deficits in patients with CMT and ClC‐1 inhibition in CMT animal models	20
Issue Information	20
Cocaine use is associated with cerebral white matter hyperintensities in HIV disease	20

Seizures and electrophysiological features in familial cortical myoclonic tremor with epilepsy 1	20
Artificial intelligence extension of the OSCAR‐IB criteria	19
Well‐being on supportive techniques in amyotrophic lateral sclerosis: from neurologists' perspective	19
Blended phenotype of TECPR2‐associated hereditary sensory‐autonomic neuropathy and Temple syndrome	19
Psychotropic medication use and Parkinson's disease risk amongst older women	19
Natural history and survival rate of familial amyloidosis with polyneuropathy: A nationwide databank	19
Late‐onset Krabbe disease presenting as spastic paraplegia – implications of GCase and CTSB/D	19
Retinal hypoplasia and degeneration result in vision loss in Friedreich ataxia	19
Clinicoradiologic data of familial cerebral cavernous malformation with age‐related disease burden	18
Targeted Long‐Read Sequencing as a Single Assay Improves the Diagnosis of Spastic‐Ataxia Disorders	18
Structural and functional connectivity alteration patterns of the cingulate gyrus in Type 2 diabetes	18
Plasma calcitonin gene‐related peptide (CGRP) in migraine and endometriosis during the menstrual cycle	18
Comparison of two corticosteroid regimens on brain volumetrics in patients with Duchenne muscular dystrophy	18
Circannual seizure provocation as the day lengthens in the northern and southern hemispheres	18
Drug‐refractory myasthenia gravis: Clinical characteristics, treatments, and outcome	18
Mexiletine in spinal and bulbar muscular atrophy: a randomized controlled trial	17
A contemporary review of therapeutic and regenerative management of intracerebral hemorrhage	17
Automated assessment of EEG background for neurodevelopmental prediction in neonatal encephalopathy	17
Safety and efficacy of intravenous thrombolytic therapy in the extended window up to 24 hours: A systematic review and meta‐analysis	17
Rethinking antisense oligonucleotide therapeutics for amyotrophic lateral sclerosis	17
FDG‐PET patterns associate with survival in patients with prion disease	17
Plasma exchange with albumin replacement for Alzheimer's disease treatment induced changes in serum and cerebrospinal fluid inflammatory mediator levels	17
A meta‐analysis comparing first‐line immunosuppressants in neuromyelitis optica	16
Study on clinical features and factors related to long‐term outcomes of antibody‐negative autoimmune encephalitis	16
Exhaustive clinical examination of etiology and initial response to first‐line treatment in 577 children with infantile epileptic spasm syndrome children: A 5‐year retrospective observational study	16
Endovascular thrombectomy versus medical management on outcomes with infarct volumes more than 70 mL	15
Alemtuzumab treatment for multiple sclerosis in Austria: An observational long‐term outcome study	15
Focal lesions following intracerebral gene therapy for mucopolysaccharidosis IIIA	15
	15
Muscle hypertrophy following acquired neurogenic injury: systematic review and analysis of existing literature	15
Abnormal dynamic functional connectivity in young nondisabling intracerebral hemorrhage patients	15
Epilepsy in Duchenne and Becker muscular dystrophies	15
ALS Identified: two‐year findings from a sponsored ALS genetic testing program	15
Vinpocetine improved neuropsychiatric and epileptic outcomes in a patient with a GABRA1 loss‐of‐function variant	15
Issue Information	15
Impact of the National Amyotrophic Lateral Sclerosis Registry: Analysis of Registry‐funded Research	14
The predictive value of normal EEGs in dementia due to Alzheimer’s disease	14
	14
Clinical trial of raltegravir, an integrase inhibitor, in HAM/TSP	14
Intranasal neuropeptide Y1 receptor antagonism improves motor deficits in symptomatic SOD1 ALS mice	14
Neurofilament light chain is a cerebrospinal fluid biomarker in hereditary spastic paraplegia	14
Brain MRS correlates with mitochondrial dysfunction biomarkers in MELAS‐associated mtDNA mutations	14
Aseptic meningitis and Fabry disease	14
Efficacy of immunotherapy and prognosis in anti‐LGI1 encephalitis patients: A meta‐analysis	14
Using electronic health data to explore effectiveness of ICU EEG and anti‐seizure treatment	13
Infantile‐onset parkinsonism, dyskinesia, and developmental delay: do not forget polyglutamine defects!	13
In‐hospital recurrent stroke in ipsilateral carotid web patients undergoing thrombectomy	13
Heart meets brain: A 25‐year‐old with a constellation of neurologic symptoms and heart failure	13
Spatiotemporal spinal cord stimulation with real‐time triggering exoskeleton restores walking capability: a case report	13
MicroRNAsignatures in genetic frontotemporal dementia and amyotrophic lateral sclerosis	13
Validation and adjustment of modified Erasmus GBS outcome score in Bangladesh	13
	13
	13
Issue Information	13
Proteomic networks of gray and white matter reveal tissue‐specific changes in human tauopathy	13
Cardiac troponin T as a serum biomarker of respiratory impairment in amyotrophic lateral sclerosis	13
Scrambler therapy for treatment of poststroke pain	13
Expanding molecular and clinical spectrum of CPT1C‐associated hereditary spastic paraplegia (SPG73)—a case series	13
Alterations in metabolic biomarkers and their potential role in amyotrophic lateral sclerosis	13
Epigenetic control of ataxin‐1 in multiple sclerosis	12
Testing awareness in focal seizures: Clinical practice and interpretation of current guidelines	12
Corrigendum	12
COVID‐19‐associated immune‐mediated encephalitis mimicking acute‐onset Creutzfeldt‐Jakob disease	12
The case of a 49‐year‐old man with involuntary toe movements	12
Dynamic effects of prognostic factors and individual survival prediction for amyotrophic lateral sclerosis disease	12
Clinical variability associated with intronic FGF14 GAA repeat expansion in Japan	12
Subclinical imaging activity in multiple sclerosis patients during war‐related psychological stress	12
Association of serum Spp1 levels with disease progression in ALS and SBMA	12
Evolution of disability in spinocerebellar ataxias type 1, 2, 3, and 6	12
Recurrent seizure‐related GRIN1 variant: Molecular mechanism and targeted therapy	12
Peripheral nervous system manifestations of MOG antibody associated disease	12
Comparison of SimoaTM and EllaTM to assess serum neurofilament‐light chain in multiple sclerosis	12
Corrigendum	12
Adult‐onset leukoencephalopathy caused by CSF1R mutations: Is all that glitters gold?	11
Disease progression and brain atrophy in NMDAR encephalitis: Associated factor & clinical implication	11
Visual atrophy rating scales and amyloid PET status in an Alzheimer's disease clinical cohort	11
Corneal nerve loss predicts dementia in patients with mild cognitive impairment	11
High diagnostic performance of plasma and cerebrospinal fluid beta‐synuclein for sporadic Creutzfeldt–Jakob disease	11
Longitudinal Trajectories of Digital Cognitive Biomarkers for Multiple Sclerosis	11
No evidence that herpes zoster is associated with increased risk of dementia diagnosis	11

Propensity matched comparison of omaveloxolone treatment to Friedreich ataxia natural history data	11
Novel CAPN1 missense variants in complex hereditary spastic paraplegia with early‐onset psychosis	11
A potential biomarker of cognitive impairment: The olfactory dysfunction and its genes expression	11
Cerebellar impulsivity–compulsivity assessment scale	11
Home infusions of natalizumab for people with multiple sclerosis: a pilot randomised crossover trial	11
Comparison of stress hyperglycemia ratio and glycemic gap on acute ICH in‐hospital outcomes	11
Adaptive behavior assessed by Vineland‐3 as comprehensive outcome measure in vanishing white matter	11
Association between brain health outcomes and metabolic risk factors in persons with diabetes	11
Factors influencing the acute pentylenetetrazole‐induced seizure paradigm and a literature review	11
Lipid levels and the risk of dementia: A dose–response meta‐analysis of prospective cohort studies	11
Systemic inflammatory markers and EEG features of children with FIRES receiving anakinra	11
Molecularly targeted treatment of recurrent anaplastic astrocytoma – a case report	11
Correlation between spinal cord stimulation analgesia and cortical dynamics in pain management	11
Asymptomatic spinal lesions in patients with AQP4‐IgG‐positive NMOSD: A real‐world cohort study	11
Multiple sclerosis and inflammatory bowel disease: A systematic review and meta‐analysis	11
Responsive neurostimulation for focal motor status epilepticus	11
Novel Phenotypes and Deep Intronic Variant Expand TH‐Associated Dopa‐Responsive Dystonia Spectrum	11
Seizure reduction in TSC2‐mutant mouse model by an mTOR catalytic inhibitor	11
Effects of tirofiban on large vessel occlusion stroke are modified by etiology and renal function	11
Early‐onset Alzheimer's disease shows a distinct neuropsychological profile and more aggressive trajectories of cognitive decline than late‐onset	11
Childhood‐onset progressive dystonia associated with pathogenic truncating variants in CHD8	10
Issue Information	10
Diagnostic Challenge in Frontal Variant Alzheimer's Disease With Low Amyloid‐β PET Retention	10
Multiple sclerosis clinical decision support system based on projection to reference datasets	10
Identification of fibrinogen as a plasma protein binding partner for lecanemab biosimilar IgG	10
Does long‐term phenytoin have a place in Dravet syndrome?	10
Visual Snow Syndrome is unstable: A longitudinal investigation of VSS symptoms in a Naïve population	10
White matter microstructures in Parkinson's disease with and without impulse control behaviors	10
Longitudinal change in TSPO PET imaging in progressive multiple sclerosis	10
The case of a 60‐year‐old man with decline in job performance and changes in personality and judgment	10
Women's reproductive traits and ischemic stroke: a two‐sample Mendelian randomization study	10
RNA mis‐splicing in children with congenital myotonic dystrophy is associated with physical function	10
aHSCT is superior to alemtuzumab in maintaining NEDA and improving cognition in multiple sclerosis	10
Correlation of slow‐wave sleep with motor and nonmotor progression in Parkinson's disease	10
Issue Information	10
Provisional practice recommendation for the management of myopathy in VCP‐associated multisystem proteinopathy	10
Mobile digital gait analysis objectively measures progression in hereditary spastic paraplegia	10
Reply to: “Inappropriate interpretation of non‐pathogenic HTRA1 variant as pathogenic”	10
Annual stability of the plasma Aß40/42 ratio and associated factors	10
LGMDD1 natural history and phenotypic spectrum: Implications for clinical trials	10
A sequential guide to identify neonates with low bacterial meningitis risk: a multicenter study	10
SARS‐COV‐2 a trigger of myelin oligodendrocyte glycoprotein‐associated disorder	10
Capturing what matters: Patient‐reported LGI1‐ANTibody encephalitis outcome RatiNg scale (LANTERN)	9
Mitochondrial DNA disorders in neuromuscular diseases in diverse populations	9
Transcriptomic signature of painful human neurofibromatosis type 2 schwannomas	9
Longitudinal study of immunity toSARS‐CoV2in ocrelizumab‐treatedMSpatients up to 2 years afterCOVID‐19 vaccination	9
Deep clinicopathological phenotyping identifies a previously unrecognized pathogenic EMD splice variant	9
First‐ever acute ischemic strokes in HIV‐infected persons: A case–control study from stroke units	9
The Impact of In‐Hospital Disease Modifying Treatments on Mental and Physical Burden in Caregiver of Patients With MS	9
Genotype‐function‐phenotype correlations for SCN1A variants identified by clinical genetic testing	9
Radiomics in glioma: emerging trends and challenges	9
Issue Information	9
Socioeconomic status moderates associations between hippocampal development and cognition in preterms	9
	9
	9
Pituitary neuroendocrine tumor: A neuropsychological comparison with intra‐axial tumor	9
Change of guard at ACTN	9
Dynamic FDG‐PET demonstration of functional brain abnormalities	9
Comparison of offspring outcomes in women with and without epilepsy	9
High‐Fat and Low‐Carbohydrate Dietary Environments Are Linked to Reduced Idiopathic Epilepsy Incidence and Prevalence	9
An ordinal clinical score predicts seizure freedom after minimally invasive epilepsy surgery	9
Patterns of myelinated nerve fibers loss in transthyretin amyloid polyneuropathy and mimics	9
Where neurostimulation meets neurodegeneration in Parkinson's disease related to GBA variants	9
Epidemiology of autoimmune encephalitis and comparison to infectious causes—Experience from a tertiary center	9
Percentage brain volume change in multiple sclerosis mainly reflects white matter and cortical volume	9
Interaction between sex and neurofilament light chain on brain structure and clinical severity in Huntington’s disease	8
Issue Information	8
B‐cell depletion limits HTLV‐1‐infected T‐cell expansion and ameliorate HTLV‐1‐associated myelopathy	8
Effects of intravenous pulse methylprednisolone in neuromyelitis optica during the acute phase	8
	8
Common pathophysiology for ANXA11 disorders caused by aspartate 40 variants	8
Clinical utility of cerebrospinal fluid biomarkers measured by LUMIPULSE® system	8
Fulminant leptomeningeal disease diagnosed as comutant H3F3A and FGFR diffuse midline glioma	8
Novel mutations in HTRA1‐related cerebral small vessel disease and comparison with CADASIL	8
Proteomic profiling of sporadic late‐onset nemaline myopathy	8
Dystonia, spastic tetraplegia, and ataxia due to a novel mutation in the dynamin domain of OPA1	8
Comparison between mono‐tacrolimus and mono‐glucocorticoid in the treatment of myasthenia gravis	8
Sustained immunotolerance in multiple sclerosis after stem cell transplant	8
Issue Information	8
No pain, no strain: Targin® mitigates pain and constipation following spinal cord injury	8
Accuracy of artificial intelligence software for CT angiography in stroke	8
The case of a 75‐year‐old male with confusion and acute blindness	8
Issue Information	8
New phenotype of RTN2‐related spectrum: Complicated form of spastic paraplegia‐12	8
Reply to: The need for evidence‐based treatment decisions in spinal muscular atrophy type 0	8
Clinical characteristics of double negative atypical inflammatory demyelinating disease: A prospective study	8
Clinical importance of changes in magnetic resonance biomarkers for Duchenne muscular dystrophy	8
Temporopolar blurring signifies abnormalities of white matter in mesial temporal lobe epilepsy	8
Progressive myoclonic ataxia as an initial symptom of typical type I sialidosis with NEU1 mutation	8
Shifting patterns of multiple sclerosis treatment in a highly prevalent United States population	8
Issue Information	8
Issue Information	8
The potassium channel Kv1.3 as a therapeutic target for immunocytoprotection after reperfusion	7
Pituitary cyclase‐activating polypeptide targeted treatments for the treatment of primary headache disorders	7
Genome and RNA sequencing boost neuromuscular diagnoses to 62% from 34% with exome sequencing alone	7